menu
    • menu

    Company profile for KALEO INC

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Kaléo is a pharmaceutical company dedicated to putting a new generation of life-saving personal medical products in your hands. We believe you are the expert on how your medical condition impacts your life and so we bring you into the product development process. Each kaléo product combines an established drug with an innovative delivery platform with the goal of achieving superiority over the current standard of care and co...
    Kaléo is a pharmaceutical company dedicated to putting a new generation of life-saving personal medical products in your hands. We believe you are the expert on how your medical condition impacts your life and so we bring you into the product development process. Each kaléo product combines an established drug with an innovative delivery platform with the goal of achieving superiority over the current standard of care and cost effectiveness. Ultimately, the goal is to provide peace of mind you can carry with you.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    KALEO INCUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    111 Virginia Street
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://kaleo.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kaléo unveils 58 commercial layoffs across multiple US states
    Kaléo unveils 58 commercial layoffs across multiple US states

    07 Oct 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/kaleo-unveils-58-layoffs-days-after-pledging-double-office-commercial-team-epipen-rival-auvi

    FIERCE PHARMA
    07 Oct 2024
    Share Share
    GSK, Amneal and Kaleo walk back patents after FTC's challenge
    GSK, Amneal and Kaleo walk back patents after FTC's challenge

    21 Dec 2023

    // Angus Liu FIERCE PHARMA

    https://www.fiercepharma.com/pharma/gsk-amneal-and-kaleo-pull-patents-fda-listing-after-ftc-challenge

    Angus Liu FIERCE PHARMA
    21 Dec 2023
    Share Share
    Kaléo Announces Executive Appointments and New Government Business Unit
    Kaléo Announces Executive Appointments and New Government Business Unit

    11 Aug 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/08/11/2496765/0/en/Kal%C3%A9o-Announces-Executive-Appointments-and-New-Government-Business-Unit.html

    GLOBENEWSWIRE
    11 Aug 2022
    Share Share
    Valeo Pharma enters agreement with Kaleo to produce epinephrine auto-injector
    Valeo Pharma enters agreement with Kaleo to produce epinephrine auto-injector

    02 Aug 2022

    // PROACTIVEINVESTORS

    https://www.proactiveinvestors.com/companies/news/988995/valeo-pharma-enters-into-agreement-with-kaleo-to-produce-epinephrine-auto-injector-for-canadian-market-988995.html

    PROACTIVEINVESTORS
    02 Aug 2022
    Share Share
    FDA Approves Kaléo’s 10 mg Naloxone Auto-Injector for Weaponized Opioids
    FDA Approves Kaléo’s 10 mg Naloxone Auto-Injector for Weaponized Opioids

    02 Mar 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220302005211/en

    BUSINESSWIRE
    02 Mar 2022
    Share Share
    Marathon Asset Management to acquire pharmaceutical firm Kaléo for $310m
    Marathon Asset Management to acquire pharmaceutical firm Kaléo for $310m

    30 Nov 2021

    // PHARMACEUTICAL-TECHNOLOGY

    https://www.pharmaceutical-technology.com/news/marathon-to-acquire-kaleo/

    PHARMACEUTICAL-TECHNOLOGY
    30 Nov 2021
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search